| Net Cash Provided by (Used in) Operating Activities |
105K |
USD |
-45.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-218K |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
4.5K |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
15M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
8.47M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-109K |
USD |
-331% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
347K |
USD |
-15.7% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
421K |
USD |
-20.6% |
Q1 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
53.2K |
USD |
+15.9% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
80.8K |
USD |
+3.99% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
23.7K |
USD |
-57.4% |
Q1 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
-33.4K |
USD |
-1781% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
74.6K |
USD |
-37.6% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
84K |
USD |
+3.94% |
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q4 2023 |
FY 2023 |
| Current Income Tax Expense (Benefit) |
252K |
USD |
+20.3% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
4M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
96.2K |
USD |
+14.4% |
Q1 2025 |
Q3 2025 |
| Additional Paid in Capital |
987K |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
980 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
270K |
USD |
+51.3% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |